Top compounds associated with response to NONO


Feature Type Standardized
Nominal ANOVA
mRNA parbendazole CTRPv2 pan-cancer AAC 0.16 1e-06
mRNA Doxorubicin CTRPv2 pan-cancer AAC 0.15 1e-06
mRNA NVP-231 CTRPv2 pan-cancer AAC 0.16 1e-06
mRNA FQI-2 CTRPv2 pan-cancer AAC 0.16 1e-06
mRNA NSC-207895 GDSC1000 pan-cancer AAC 0.16 1e-06
mRNA barasertib CTRPv2 pan-cancer AAC 0.16 2e-06
mRNA doxorubicin:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.16 2e-06
mRNA PF-184 CTRPv2 pan-cancer AAC 0.16 2e-06
mRNA ISOX:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC 0.17 2e-06
mRNA paclitaxel CTRPv2 pan-cancer AAC 0.16 2e-06
Download CSV